Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab maintenance versus observation in CD20-positive B-cell non-Hodgkin lymphoma
ISRCTN74547745Phase 3Completed
- Sponsor
- Heidelberg University
- Start
- Jun 2002
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in mature B-cell lymphoma comparing Rituximab maintenance with Observation (2 arms). Primary endpoint: Event-free survival. Started Jun 2002; status: completed.
02
Drugs
rituximab
03
Conditions
mature B-cell lymphoma
Beyond the preview
Go deeper on ISRCTN74547745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74547745.